Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director · Chairman and CEO | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 54.005 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 54.005 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 53.2963 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 53.2963 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 65.3344 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 7.9884 · Balance 65.3344 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 70.4281 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 9.5728 · Balance 70.4281 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 65.0639 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 11.6845 · Balance 65.0639 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 67.0809 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 13.2391 · Balance 67.0809 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 50.6104 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 19.5865 · Balance 50.6104 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 25, 2021 Filed Aug 9, 2021 21:25 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 116 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-019189 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,522,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 20:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 24,655 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001437749-21-016057 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,655 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 20:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,078 | $0.00 Strike: $15.54 | $0.00 |
DisclosureSEC source: 0001437749-21-016057 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,078 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 20:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 24,655 | $14.13 | $348,375.15 |
DisclosureSEC source: 0001437749-21-016057 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,522,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 20:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,078 | $15.54 | $109,992.12 |
DisclosureSEC source: 0001437749-21-016057 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,498,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| June 10, 2021 Filed Jun 30, 2021 20:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 1,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-016057 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,490,963 Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-014255 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21 Underlying: Common Stock · 10 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-014255 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70 Underlying: Common Stock · 8 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-014255 · rdgdoc.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134 Underlying: Common Stock · 10 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-014255 · rdgdoc.xml · derivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75 Underlying: Common Stock · 5 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-014255 · rdgdoc.xml · derivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116 Underlying: Common Stock · 5 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 13, 2021 Filed May 13, 2021 23:25 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 2,404 | $48.31 | $116,135.56 |
DisclosureSEC source: 0001437749-21-012148 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,492,833 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $47.63 to $48.84. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 12, 2021 Filed May 13, 2021 23:25 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 20,951 | $48.12 | $1,008,204.02 |
DisclosureSEC source: 0001437749-21-012148 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,495,237 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $47.75 to $48.87. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 11, 2021 Filed May 13, 2021 23:25 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 26,275 | $48.04 | $1,262,145.90 |
DisclosureSEC source: 0001437749-21-012148 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,516,188 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $47.76 to $49.03. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 10, 2021 Filed May 10, 2021 22:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 7,200 | $49.87 | $359,039.52 |
DisclosureSEC source: 0001437749-21-011568 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,542,463 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $49.06 to $50.50. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 07, 2021 Filed May 10, 2021 22:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 42,762 | $51.00 | $2,181,007.39 |
DisclosureSEC source: 0001437749-21-011568 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,549,663 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.66 to $51.58. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 43,944 | $51.27 | $2,253,004.49 |
DisclosureSEC source: 0001437749-21-011568 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,592,425 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.75 to $52.47. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 05, 2021 Filed May 5, 2021 23:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 31,576 | $51.68 | $1,631,847.68 |
DisclosureSEC source: 0001437749-21-010969 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,636,369 F4 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.49 to $52.18. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 04, 2021 Filed May 5, 2021 23:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 24,888 | $51.62 | $1,284,611.54 |
DisclosureSEC source: 0001437749-21-010969 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,667,945 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $51.25 to $51.94. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 03, 2021 Filed May 5, 2021 23:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 25,000 | $51.31 | $1,282,812.50 |
DisclosureSEC source: 0001437749-21-010969 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 1. Disclosed balance after: 0 F1 · kind: These shares were sold by LeMaitre Family LLC. LeMaitre Family LLC is 100% owned by the LeMaitre 2003 Children's Trust. Christopher Lynch and the Reporting Person serve as co-trustees for the LeMaitre 2003 Children's Trust, which was formed for the benefit of the children of George D. LeMaitre, the Issuer's founder, and Cornelia W. LeMaitre. The Reporting Person disclaims ownership of the securities transacted and/or held by LeMaitre Family LLC except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. F1 · shares: These shares were sold by LeMaitre Family LLC. LeMaitre Family LLC is 100% owned by the LeMaitre 2003 Children's Trust. Christopher Lynch and the Reporting Person serve as co-trustees for the LeMaitre 2003 Children's Trust, which was formed for the benefit of the children of George D. LeMaitre, the Issuer's founder, and Cornelia W. LeMaitre. The Reporting Person disclaims ownership of the securities transacted and/or held by LeMaitre Family LLC except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.54 to $53.07. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 25, 2021 Filed Mar 30, 2021 01:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-007517 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11 Underlying: Common Stock · 11 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 25, 2021 Filed Mar 30, 2021 01:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-007517 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62 Underlying: Common Stock · 9 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 25, 2021 Filed Mar 30, 2021 01:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-007517 · rdgdoc.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124 Underlying: Common Stock · 11 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 25, 2021 Filed Mar 30, 2021 01:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-007517 · rdgdoc.xml · derivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70 Underlying: Common Stock · 5 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 25, 2021 Filed Mar 30, 2021 01:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-007517 · rdgdoc.xml · derivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111 Underlying: Common Stock · 6 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 22,900 | $48.61 | $1,113,157.55 |
DisclosureSEC source: 0001437749-21-005930 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 1. Disclosed balance after: 25,000 F1 · security: These shares were sold by LeMaitre Family LLC. LeMaitre Family LLC is 100% owned by the LeMaitre 2003 Children's Trust. Christopher Lynch and the Reporting Person serve as co-trustees for the LeMaitre 2003 Children's Trust, which was formed for the benefit of the children of George D. LeMaitre, the Issuer's founder, and Cornelia W. LeMaitre. The Reporting Person disclaims ownership of the securities transacted and/or held by LeMaitre Family LLC except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $47.61 to $49.70. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 2,100 | $49.76 | $104,498.31 |
DisclosureSEC source: 0001437749-21-005930 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 1. Disclosed balance after: 47,900 F1 · security: These shares were sold by LeMaitre Family LLC. LeMaitre Family LLC is 100% owned by the LeMaitre 2003 Children's Trust. Christopher Lynch and the Reporting Person serve as co-trustees for the LeMaitre 2003 Children's Trust, which was formed for the benefit of the children of George D. LeMaitre, the Issuer's founder, and Cornelia W. LeMaitre. The Reporting Person disclaims ownership of the securities transacted and/or held by LeMaitre Family LLC except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $49.01 to $50.08. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 23:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 1,400 | $49.07 | $68,704.16 |
DisclosureSEC source: 0001437749-21-005282 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,692,833 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $48.07 to $50.74. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 01:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 48,150 | $51.20 | $2,465,275.19 |
DisclosureSEC source: 0001437749-21-004909 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,694,233 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.55 to $52.55. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 54,184 | $51.51 | $2,790,839.03 |
DisclosureSEC source: 0001437749-21-004909 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,742,383 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.36 to $52.98. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 42,869 | $51.41 | $2,203,728.10 |
DisclosureSEC source: 0001437749-21-004909 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,796,567 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.73 to $52.23. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 23:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,610 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-20-026000 · rdgdoc.xml · derivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,440 Underlying: Common Stock · 8,610 shares Expires 2024-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. F6 · derivative.expiration_date: The expiration date of this option to the extent it is an incentive stock option is 12/20/2024, and the expiration date of this option to the extent it is a nonqualified stock option is 12/20/2026. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 23:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,747 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001437749-20-026000 · rdgdoc.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,240 Underlying: Common Stock · 12,747 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. F5 · derivative.expiration_date: The expiration date of this option to the extent it is an incentive stock option is 12/19/2023, and the expiration date of this option to the extent it is a nonqualified stock option is 12/19/2025. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 23:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 34,957 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001437749-20-026000 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,304 Underlying: Common Stock · 34,957 shares Expires 2022-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. F4 · derivative.expiration_date: The expiration date of this option to the extent it is an incentive stock option is 12/22/2022, and the expiration date of this option to the extent it is a nonqualified stock option is 12/22/2024. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 23:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 8,610 | $35.48 | $305,482.80 |
DisclosureSEC source: 0001437749-20-026000 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,839,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 23:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 12,747 | $23.56 | $300,319.32 |
DisclosureSEC source: 0001437749-20-026000 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,830,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 23:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 34,957 | $31.30 | $1,094,154.10 |
DisclosureSEC source: 0001437749-20-026000 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,818,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 23, 2020 Filed Jan 9, 2021 02:21 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,610 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-21-000451 · rdgdoc.xml · derivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,440 Underlying: Common Stock · 8,610 shares Expires 2024-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. F6 · derivative.expiration_date: The expiration date of this option to the extent it is an incentive stock option is 12/20/2024, and the expiration date of this option to the extent it is a nonqualified stock option is 12/20/2026. Read SEC document |
| December 23, 2020 Filed Jan 9, 2021 02:21 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,747 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001437749-21-000451 · rdgdoc.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,240 Underlying: Common Stock · 12,747 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. F5 · derivative.expiration_date: The expiration date of this option to the extent it is an incentive stock option is 12/19/2023, and the expiration date of this option to the extent it is a nonqualified stock option is 12/19/2025. Read SEC document |
| December 23, 2020 Filed Jan 9, 2021 02:21 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 34,957 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001437749-21-000451 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,304 Underlying: Common Stock · 34,957 shares Expires 2022-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. F4 · derivative.expiration_date: The expiration date of this option to the extent it is an incentive stock option is 12/22/2022, and the expiration date of this option to the extent it is a nonqualified stock option is 12/22/2024. Read SEC document |
| December 23, 2020 Filed Jan 9, 2021 02:21 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 8,610 | $35.48 | $305,482.80 |
DisclosureSEC source: 0001437749-21-000451 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,839,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 23, 2020 Filed Jan 9, 2021 02:21 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 12,747 | $23.56 | $300,319.32 |
DisclosureSEC source: 0001437749-21-000451 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,830,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 23, 2020 Filed Jan 9, 2021 02:21 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 34,957 | $31.30 | $1,094,154.10 |
DisclosureSEC source: 0001437749-21-000451 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,818,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 22, 2020 Filed Dec 24, 2020 02:49 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-025901 · rdgdoc.xml · derivative · entry 8 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80 Underlying: Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 22, 2020 Filed Dec 24, 2020 02:49 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 522 | $37.38 | $19,512.36 |
DisclosureSEC source: 0001437749-20-025901 · rdgdoc.xml · nonDerivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,783,107 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 22, 2020 Filed Dec 24, 2020 02:49 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-025901 · rdgdoc.xml · nonDerivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,783,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 23:27 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-025996 · rdgdoc.xml · derivative · entry 10 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80 Underlying: Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 23:27 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 522 | $37.38 | $19,512.36 |
DisclosureSEC source: 0001437749-20-025996 · rdgdoc.xml · nonDerivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,783,114 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 23:27 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-025996 · rdgdoc.xml · nonDerivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,783,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 22, 2020 Filed Jan 9, 2021 02:19 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-000450 · rdgdoc.xml · derivative · entry 10 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.